Midazolam induces apoptosis in MA-10 mouse leydig tumor cells through caspase activation and the involvement of MAPK signaling pathway

Edmund Cheung So, Yu Xuan Lin, Chi Hao Tseng, Bo Syong Pan, Ka Shun Cheng, Kar Lok Wong, Lyh Jyh Hao, Yang Kao Wang, Bu Miin Huang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose: The present study aims to investigate how midazolam, a sedative drug for clinical use with cytotoxicity on neuronal and peripheral tissues, induced apoptosis in MA-10 mouse Leydig tumor cells. Methods: The apoptotic effect and underlying mechanism of midazolam to MA-10 cells were investigated by flow cytometry assay and Western blotting methods. Results: Data showed that midazolam induced the accumulation of the MA-10 cell population in the sub-G1 phase and a reduction in the G2/M phase in a time- and dose-dependent manner, suggesting an apoptotic phenomenon. Midazolam could also induce the activation of caspase-8, -9, and -3 and poly (ADP-ribose) polymerase proteins. There were no changes in the levels of Bax and cytochrome-c, whereas Bid was significantly decreased after midazolam treatment. Moreover, midazolam decreased both pAkt and Akt expression. In addition, midazolam stimulated the phosphorylation of p38 and c-Jun NH2-terminal kinase but not extracellular signal-regulated kinase. Conclusion: Midazolam could induce MA-10 cell apoptosis through the activation of caspase cascade, the inhibition of pAkt pathway, and the induction of p38 and c-Jun NH2-terminal kinase pathways.

Original languageEnglish
Pages (from-to)211-221
Number of pages11
JournalOncoTargets and Therapy
Volume7
DOIs
Publication statusPublished - Feb 13 2014

Fingerprint

Leydig Cell Tumor
Midazolam
Caspases
Apoptosis
JNK Mitogen-Activated Protein Kinases
Poly(ADP-ribose) Polymerases
Caspase 9
Caspase 8
G2 Phase
Extracellular Signal-Regulated MAP Kinases
G1 Phase
Cytochromes c
Hypnotics and Sedatives
Cell Division
Flow Cytometry
Western Blotting
Phosphorylation

Keywords

  • Akt
  • Apoptosis
  • Caspase
  • MA-10 cell
  • MAPKs
  • Midazolam

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Midazolam induces apoptosis in MA-10 mouse leydig tumor cells through caspase activation and the involvement of MAPK signaling pathway. / So, Edmund Cheung; Lin, Yu Xuan; Tseng, Chi Hao; Pan, Bo Syong; Cheng, Ka Shun; Wong, Kar Lok; Hao, Lyh Jyh; Wang, Yang Kao; Huang, Bu Miin.

In: OncoTargets and Therapy, Vol. 7, 13.02.2014, p. 211-221.

Research output: Contribution to journalArticle

So, Edmund Cheung ; Lin, Yu Xuan ; Tseng, Chi Hao ; Pan, Bo Syong ; Cheng, Ka Shun ; Wong, Kar Lok ; Hao, Lyh Jyh ; Wang, Yang Kao ; Huang, Bu Miin. / Midazolam induces apoptosis in MA-10 mouse leydig tumor cells through caspase activation and the involvement of MAPK signaling pathway. In: OncoTargets and Therapy. 2014 ; Vol. 7. pp. 211-221.
@article{1a50c327af724b7e8c89b9c2a0768a0f,
title = "Midazolam induces apoptosis in MA-10 mouse leydig tumor cells through caspase activation and the involvement of MAPK signaling pathway",
abstract = "Purpose: The present study aims to investigate how midazolam, a sedative drug for clinical use with cytotoxicity on neuronal and peripheral tissues, induced apoptosis in MA-10 mouse Leydig tumor cells. Methods: The apoptotic effect and underlying mechanism of midazolam to MA-10 cells were investigated by flow cytometry assay and Western blotting methods. Results: Data showed that midazolam induced the accumulation of the MA-10 cell population in the sub-G1 phase and a reduction in the G2/M phase in a time- and dose-dependent manner, suggesting an apoptotic phenomenon. Midazolam could also induce the activation of caspase-8, -9, and -3 and poly (ADP-ribose) polymerase proteins. There were no changes in the levels of Bax and cytochrome-c, whereas Bid was significantly decreased after midazolam treatment. Moreover, midazolam decreased both pAkt and Akt expression. In addition, midazolam stimulated the phosphorylation of p38 and c-Jun NH2-terminal kinase but not extracellular signal-regulated kinase. Conclusion: Midazolam could induce MA-10 cell apoptosis through the activation of caspase cascade, the inhibition of pAkt pathway, and the induction of p38 and c-Jun NH2-terminal kinase pathways.",
keywords = "Akt, Apoptosis, Caspase, MA-10 cell, MAPKs, Midazolam",
author = "So, {Edmund Cheung} and Lin, {Yu Xuan} and Tseng, {Chi Hao} and Pan, {Bo Syong} and Cheng, {Ka Shun} and Wong, {Kar Lok} and Hao, {Lyh Jyh} and Wang, {Yang Kao} and Huang, {Bu Miin}",
year = "2014",
month = "2",
day = "13",
doi = "10.2147/OTT.S56084",
language = "English",
volume = "7",
pages = "211--221",
journal = "OncoTargets and Therapy",
issn = "1178-6930",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Midazolam induces apoptosis in MA-10 mouse leydig tumor cells through caspase activation and the involvement of MAPK signaling pathway

AU - So, Edmund Cheung

AU - Lin, Yu Xuan

AU - Tseng, Chi Hao

AU - Pan, Bo Syong

AU - Cheng, Ka Shun

AU - Wong, Kar Lok

AU - Hao, Lyh Jyh

AU - Wang, Yang Kao

AU - Huang, Bu Miin

PY - 2014/2/13

Y1 - 2014/2/13

N2 - Purpose: The present study aims to investigate how midazolam, a sedative drug for clinical use with cytotoxicity on neuronal and peripheral tissues, induced apoptosis in MA-10 mouse Leydig tumor cells. Methods: The apoptotic effect and underlying mechanism of midazolam to MA-10 cells were investigated by flow cytometry assay and Western blotting methods. Results: Data showed that midazolam induced the accumulation of the MA-10 cell population in the sub-G1 phase and a reduction in the G2/M phase in a time- and dose-dependent manner, suggesting an apoptotic phenomenon. Midazolam could also induce the activation of caspase-8, -9, and -3 and poly (ADP-ribose) polymerase proteins. There were no changes in the levels of Bax and cytochrome-c, whereas Bid was significantly decreased after midazolam treatment. Moreover, midazolam decreased both pAkt and Akt expression. In addition, midazolam stimulated the phosphorylation of p38 and c-Jun NH2-terminal kinase but not extracellular signal-regulated kinase. Conclusion: Midazolam could induce MA-10 cell apoptosis through the activation of caspase cascade, the inhibition of pAkt pathway, and the induction of p38 and c-Jun NH2-terminal kinase pathways.

AB - Purpose: The present study aims to investigate how midazolam, a sedative drug for clinical use with cytotoxicity on neuronal and peripheral tissues, induced apoptosis in MA-10 mouse Leydig tumor cells. Methods: The apoptotic effect and underlying mechanism of midazolam to MA-10 cells were investigated by flow cytometry assay and Western blotting methods. Results: Data showed that midazolam induced the accumulation of the MA-10 cell population in the sub-G1 phase and a reduction in the G2/M phase in a time- and dose-dependent manner, suggesting an apoptotic phenomenon. Midazolam could also induce the activation of caspase-8, -9, and -3 and poly (ADP-ribose) polymerase proteins. There were no changes in the levels of Bax and cytochrome-c, whereas Bid was significantly decreased after midazolam treatment. Moreover, midazolam decreased both pAkt and Akt expression. In addition, midazolam stimulated the phosphorylation of p38 and c-Jun NH2-terminal kinase but not extracellular signal-regulated kinase. Conclusion: Midazolam could induce MA-10 cell apoptosis through the activation of caspase cascade, the inhibition of pAkt pathway, and the induction of p38 and c-Jun NH2-terminal kinase pathways.

KW - Akt

KW - Apoptosis

KW - Caspase

KW - MA-10 cell

KW - MAPKs

KW - Midazolam

UR - http://www.scopus.com/inward/record.url?scp=84894238291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894238291&partnerID=8YFLogxK

U2 - 10.2147/OTT.S56084

DO - 10.2147/OTT.S56084

M3 - Article

VL - 7

SP - 211

EP - 221

JO - OncoTargets and Therapy

JF - OncoTargets and Therapy

SN - 1178-6930

ER -